Lead Assets

KWB01-A

KWB01-A shows inhibitory activities against BRD4 (BD1+BD2) and BRD2 (BD1+BD21).

We expect that KWB01-A as a novel drug candidate having activity against age-related

diseases such as diabetic retinopathy, atherosclerosis, rheumatoid arthritis,

and inflammatory diseases.

DMPK

 

KWB04-B

KWB04-B shows inhibitory activities against BRD4(BD1+BD2), BRD2 (BD1+BD2).

DMPK

 

KWB04-C

KWB04-C has BD2-specific inhibitory activity against BRD4(BD2) and BRD2(BD2).

DMPK

 

© BenoBio Co., Ltd.

  • Facebook
  • Twitter
  • YouTube
  • 회색 링크드 인 아이콘